Add to Favorites Newsroom RSS Share
fb-shareMoffitt Cancer Center
Tampa, FL USA

Our News on Newswise

Moffitt Researchers Characterize Mechanism of Action of CAR T Cells

Despite progress being made, scientists have not been completely certain of how CAR T cells function mechanistically. A team of Moffitt Cancer Center researchers addressed this uncertainty and characterized the mechanism of action of these new...
14-Feb-2019 9:00 AM EST Add to Favorites

Moffitt Cancer Center Leads the Nation in Addressing LGBTQ Health Care Disparities and Education

Moffitt launched the first nationwide survey to identify potential gaps in attitudes, knowledge and institutional practices for LGBTQ patients.
14-Jan-2019 9:15 AM EST Add to Favorites

Moffitt Cancer Center Hires New Vice Chair of the Department of Genitourinary Oncology

Manish Kohli, M.D., has joined Moffitt Cancer Center as the vice chair of the Department of Genitourinary Oncology. He also has an extensive research background, focusing on creating new ways to bring individualized care to patients.
15-Jan-2019 9:35 AM EST Add to Favorites

Moffitt Names New Associate Center Director of Community Outreach & Engagement

Moffitt Cancer Center has named Susan Thomas Vadaparampil, Ph.D., M.P.H, its first Associate Center Director of Community Outreach & Engagement. The newly created leadership role is of great importance to the cancer center, as it focuses on the...
13-Dec-2018 7:05 AM EST Add to Favorites

Moffitt Researchers Identify Novel Mechanism to Thwart KRas-driven Tumor Growth

Researchers at Moffitt Cancer Center are trying to devise alternative mechanisms to block KRas. Their recent study demonstrates that the protein GSK3 is an important mediator of KRas-dependent tumor viability. Their research was published today in...
4-Dec-2018 11:05 AM EST Add to Favorites

New Two-year Data Show 39 Percent of Non-Hodgkin Lymphoma Patients Treated with CAR T-cell Therapy Remain in Remission

A new article published today in The Lancet Oncology shows 39 percent of large B cell lymphoma patients treated with the chimeric antigen receptor T-cell therapy (CAR T) Yescarta® (axicabtagene ciloleucel) remained in remission more than two years...
2-Dec-2018 12:05 PM EST Add to Favorites

New Study Highlights CAR T-cell Therapy Success for Lymphoma When Used as Standard of Care

Moffitt Cancer Center partnered with 16 academic cancer centers to analyze real world data of 274 patients treated commercially with Yescarta® (axicabtagene ciloleucel), one of two CAR T products that is now standard of care for patients with...
1-Dec-2018 3:00 PM EST Add to Favorites

Evidence Mounts Linking Aspirin to Lower Risk of Ovarian Cancer

A new study found that women who reported taking a low-dose aspirin every day had a 23 percent lower risk of ovarian cancer compared to nonaspirin users. The research also found that women who were heavy users of nonaspirin nonsteroidal...
4-Oct-2018 11:15 AM EDT Add to Favorites


see all news

Our Experts on Newswise

AnnaGiuliano_Euroginopeningtalk_2017.jpg

Moffitt Cancer Center HPV Expert Kicked Off EUROGIN Conference

Anna Giuliano, Ph.D., director of Moffitt Cancer Center’s Center for Infection Research in Cancer, delivered the opening keynote address at the 2017 European Research Organization on Genital Infection and Neoplasia (EUROGIN) International...
10-Oct-2017 10:05 AM EDT

see all experts

Our YouTube Videos

About

Moffitt is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer. One of the three largest cancer centers in the United States based on patient volume, the Tampa-based facility is one of only 45 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s excellence in research, its contributions to clinical trials, prevention and cancer control. Moffitt is the top-ranked cancer hospital in Florida and has been listed in U.S. News & World Report as one of the “Best Hospitals” for cancer care since 1999. Moffitt devotes more than 2 million square feet to research and patient care. With more than 5,000 team members, Moffitt has an economic impact in the state of $1.9 billion. For more information, call 1-888-MOFFITT (1-888-663-3488), visit MOFFITT.org, and follow the Moffitt momentum on Facebook, Twitter and YouTube.

Contacts

Kim Polacek
Senior Public Relations Account Coordinator

Kim.Polacek@Moffitt.org

813-745-7408

Steven Blanchard
Public Relations Account Coordinator

Steven.Blanchard@Moffitt.org

813-745-1718

Sara Bondell
Public Relations Account Coodinator

Sara.Bondell@moffitt.org

813-745-1353

Patty Kim
Public Relations Manager

Patty.Kim@Moffitt.org

813-745-7322

Twitter twitter-icon

Chat now!